Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1057

1.

Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.

Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.

Carcinogenesis. 2003 Oct;24(10):1671-6. Epub 2003 Jul 4.

2.

Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.

Gao WM, Romkes M, Siegfried JM, Luketich JD, Keohavong P.

Mol Carcinog. 2006 Nov;45(11):828-32.

PMID:
16865671
3.

Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.

Hou SM, Ryk C, Kannio A, Angelini S, Fält S, Nyberg F, Husgafvel-Pursiainen K.

Environ Mol Mutagen. 2003;41(1):37-42.

PMID:
12552590
4.

DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.

Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, Cho SS.

Carcinogenesis. 2002 Aug;23(8):1321-5.

5.

Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.

De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H.

Mutat Res. 2007 Jul 28;631(2):101-10. Epub 2007 Apr 21.

PMID:
17531525
6.
7.

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.

Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R.

J Cancer Res Clin Oncol. 2008 Jun;134(6):645-52. Epub 2007 Oct 19.

PMID:
17952468
8.

Genetic polymorphisms in DNA repair genes and risk of lung cancer.

Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC.

Carcinogenesis. 2001 Apr;22(4):593-7.

9.

DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.

Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):23-9.

10.

Polymorphisms in XPD and TP53 and mutation in human lung cancer.

Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC.

Carcinogenesis. 2005 Mar;26(3):597-604. Epub 2004 Nov 25.

11.

[Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].

Xing DY, Qi J, Tan W, Miao XP, Liang G, Yu CY, Lu WF, Zhou CN, Wu M, Lin DX.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Feb;20(1):35-8. Chinese.

PMID:
12579497
12.

Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population.

Xing D, Tan W, Wei Q, Lin D.

Lung Cancer. 2002 Nov;38(2):123-9.

PMID:
12399122
13.

Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.

Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P.

Carcinogenesis. 2004 Dec;25(12):2433-41. Epub 2004 Aug 27.

14.

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65.

15.

Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.

Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, Kim CH, Park JH, Kam S, Kim IS, Jung TH.

Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):23-7.

16.

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC.

J Clin Oncol. 2004 Jul 1;22(13):2594-601. Epub 2004 Jun 1.

17.

Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.

Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1234-40.

18.

XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.

Stern MC, Johnson LR, Bell DA, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1004-11.

19.

Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC.

Cancer Res. 2002 Mar 1;62(5):1377-81.

20.

The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk.

Hou SM, Fält S, Angelini S, Yang K, Nyberg F, Lambert B, Hemminki K.

Carcinogenesis. 2002 Apr;23(4):599-603.

Items per page

Supplemental Content

Write to the Help Desk